P

Assignee

ICN PHARMACEUTICALS

US45 patents

Top patents by PatentIndex Score

US6403566B1Jun 11, 2002

Nucleosides having bicyclic sugar moiety

ICN PHARMACEUTICALS165 citations99
US6642206B2Nov 4, 2003

Monocyclic L-nucleosides, analogs and uses thereof

ICN PHARMACEUTICALS102 citations98
US6573248B2Jun 3, 2003

Monocyclic L-nucleosides, analogs and uses thereof

ICN PHARMACEUTICALS179 citations98
US6130326AOct 10, 2000

Monocyclic L-Nucleosides, analogs and uses thereof

ICN PHARMACEUTICALS139 citations98
US6083482AJul 4, 2000

Conformationally locked nucleosides and oligonucleotides

ICN PHARMACEUTICALS92 citations98
US6509320B1Jan 21, 2003

Purine L-nucleosides, analogs and uses thereof

ICN PHARMACEUTICALS83 citations97
US6479463B1Nov 12, 2002

Purine L-nucleosides, analogs and uses thereof

ICN PHARMACEUTICALS123 citations97
US6191266B1Feb 20, 2001

Sugar modified nucleosides

ICN PHARMACEUTICALS60 citations96
US6150337ANov 21, 2000

Specific modulation of Th1/Th2 cytokine expression by Ribavirin in activated T-lymphocytes

ICN PHARMACEUTICALS83 citations96
US5712378AJan 27, 1998

Sugar modified nucleosides and their use for synthesis of oligonucleotides

ICN PHARMACEUTICALS71 citations96
US5681940AOct 28, 1997

Sugar modified nucleosides and oligonucleotides

ICN PHARMACEUTICALS140 citations96
US4093624AJun 6, 1978

1,2,4-Thiadiazolidine-3,5-dione

ICN PHARMACEUTICALS84 citations96
US6552183B1Apr 22, 2003

Moncyclic L-nucleosides analogs

ICN PHARMACEUTICALS74 citations95
US5767097AJun 16, 1998

Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes

ICN PHARMACEUTICALS212 citations95
US6063772AMay 16, 2000

Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes

ICN PHARMACEUTICALS111 citations94
US6017898AJan 25, 2000

Inhibition of tumor growth by antisense oligonucleotides for IL-8 and IL-8 receptor

ICN PHARMACEUTICALS83 citations94
US5849903ADec 15, 1998

Antisense oligonucleotides for IL-8 and IL-8 receptor

ICN PHARMACEUTICALS71 citations94
US5723589AMar 3, 1998

Carbohydrate conjugated bio-active compounds

ICN PHARMACEUTICALS50 citations94
USD408957SApr 27, 1999

Portion of a transport and storage vessel for radioactive materials

ICN PHARMACEUTICALS30 citations93
US4093714AJun 6, 1978

9β-D-Arabinofuranosylpurine nucleotides and method of use

ICN PHARMACEUTICALS52 citations92
US4432975AFeb 21, 1984

Process for introducing vitamin B-12 into the bloodstream

ICN PHARMACEUTICALS92 citations90
US4036840AJul 19, 1977

2-Substituted-s-triazolo[1,5a]pyrimidines

ICN PHARMACEUTICALS45 citations90
US4021556AMay 3, 1977

Xanthine oxidase inhibitors

ICN PHARMACEUTICALS34 citations90
US5969135AOct 19, 1999

Oligonucleotide analogs with an amino acid or a modified amino alcohol residue

ICN PHARMACEUTICALS28 citations89
US5990299ANov 23, 1999

Control of CD44 gene expression for therapeutic use

ICN PHARMACEUTICALS29 citations87
US3984396AOct 5, 1976

1-(β,-D-ribofuranosyl)-1,2,4-triazole acid esters

ICN PHARMACEUTICALS29 citations82
US4093617AJun 6, 1978

3,5,7-Trisubstituted pyrazolo[1,5-a]pyrimidines

ICN PHARMACEUTICALS27 citations80
US4138547AFeb 6, 1979

Process for preparing 1,2,4-triazole nucleosides

ICN PHARMACEUTICALS24 citations78
US5783832AJul 21, 1998

Packaging with centrifuge tube

ICN PHARMACEUTICALS7 citations74
US3991078ANov 9, 1976

N-substituted 1,2,4-triazoles

ICN PHARMACEUTICALS11 citations74
US3976545AAug 24, 1976

1,2,4-Triazol E-3-carboxamides as antiviral agents

ICN PHARMACEUTICALS17 citations74
US6613896B1Sep 2, 2003

Method of producing tiazofurin and other C-nucleosides

ICN PHARMACEUTICALS9 citations72
US3948886AApr 6, 1976

6-Substituted purine 3',5'-cyclic nucleotides

ICN PHARMACEUTICALS14 citations72
US3968101AJul 6, 1976

8-Substituted cyclic nucleotides by free radical alkylation and acylation

ICN PHARMACEUTICALS9 citations70
US5907036AMay 25, 1999

Procedures for obtaining ribo-C-nucleosides

ICN PHARMACEUTICALS7 citations69
US4058659ANov 15, 1977

6,8-Disubstituted purine derivatives of 9-β-D-ribofuranosyl 3',5'-cyclic phosphate

ICN PHARMACEUTICALS15 citations69
US4038480AJul 26, 1977

6-aminocarbonyl purine 3',5'-cyclic nucleotides

ICN PHARMACEUTICALS12 citations69
US3948885AApr 6, 1976

5-Hydroxyl-1,2,3-triazole-4-carboxamide nucleoside

ICN PHARMACEUTICALS14 citations69
US4056674ANov 1, 1977

Derivatives of 3-deazaguanine

ICN PHARMACEUTICALS8 citations65
US3968103AJul 6, 1976

1,2,3-Triazole nucleosides

ICN PHARMACEUTICALS5 citations63
US4246408AJan 20, 1981

Imidazo[1,2-a]-s-triazine

ICN PHARMACEUTICALS5 citations62
US6211201B1Apr 3, 2001

Multivalent salts of pyridostigmine and related compounds

ICN PHARMACEUTICALS6 citations60
US5763419AJun 9, 1998

Treatment of malignant tumors with 8-chloroadenosine 3',5'-cyclic monophasphate

ICN PHARMACEUTICALS2 citations60
US4328336AMay 4, 1982

9-(β-D-Ribofurandsyl)purine-6-carboxamide and related compounds

ICN PHARMACEUTICALS4 citations58
US5798250AAug 25, 1998

Facilitating hepatitus virus infection in cell culture using a membrane stressor

ICN PHARMACEUTICALS2 citations45